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Two radiochemical (Irosorb 59 and Res-O-Mat Fc59), a mechanized (DSA 560) and several manual colorimetric procedures (test com-
bination of Roche, Merck and Haury) for the determination of the total iron binding capacity were compared with the transferrin-binding
capacity (immunoprecipitation). Whereas all methods show a satisfactory correlation with the transferrin concentration, most colorimetric
procedures lead to higher values, while the Merckotcst leads to lower values for the total iron binding capacity. In some control sera the
total iron binding capacity is overestimated by several colorimetric methods, which are also subject to interference by hemoglobin. All
other procedures are unaffected by hemolysis. With the mechanization of procedures for immunoprecipitation, these methods are now to
be preferred.
Zwei radiochemische (Irosorb 59 und Res-O-Mat Fe59), ein mechanisiertes (DSA 560) und verschiedene manuelle kolorimetrische Ver-
fahren (Testkombination von Röche, Merck und Haury) zur Bestimmung der totalen Eisenbindungskapazität werden mit der Trans-
ferrin-Bindungskapazität (Immunopräzipitation) verglichen. Während alle Methoden mit der Transferrin-Konzentration ausreichend
korrelieren, führen die meisten kolorimetrischen Verfahren zu höheren und der Merckotest zu niedrigeren Werten für die totale Eisen-
bindungskapazität. In einigen Kontrollseren wird die totale Eisenbindungskapazität mit verseiliedenen kolorimetrischen Methoden zu
hoch gefunden. Die selben werden durch Hämoglobin gestört. Alle anderen Verfahren werden durch Hämolyse nicht beeinflußt. Mit der
Einführung von mechanisierten Verfahren zur immunologischen Transferrin-Bestimmung sollte diese Methode bevorzugt werden.
The total iron binding capacity of human serum is
considered to be a useful estimation of its transferrin
concentration. However, recent investigations by
various authors (1 —3), have shown, that in addition to
transferrin, other serum proteins are able to bind a small
quantity of iron ions. Therefore, the total iron binding
capacity is expected to exceed the transferrin iron
binding capacity if iron is added under saturating
conditions. In the following, this assumption was
investigated with various procedures for the determina-
tion of the total iron binding capacity in human sera.
Usually one third of the iron binding capacity of serum
is loaded with iron. After the addition of labelled iron,
the latent iron binding capacity1) can be calculated from
the ratio of bound to added 58Fe. This is measured after
all free ions have been separated from the incubation
medium by ion exchange materials, such as the Res-O-
Mat strip (Byk-Mallinckrodt) or resin sponges (Abbott).
The same procedure can be applied for the determination
of total iron binding capacity if the serum is depleted of
all iron ions. This is achieved by lowering the pH value
of the incubation medium and by'binding all free iron
ions to an Amberlite powder. After centrifugation the
supernatant consists of iron free serum which can be
used for the determination of the iron binding capacity
as described above (Byk-Mallinckrodt).
Two colorimetric procedures (Merckotest, ferrozine
method) also measure the latent iron binding capacity,
*) Total iron binding capacity ( / ) = latent kon binding
capacity (^mol/l) + serum iron concentration ( / ).
but, by the ratio of unbound to added unlabelled Fe.
Under these conditions free and protein-bound iron
must not be separated because only free Fe3+ ions react
with the chromogens bathophenanthroline and ferro-
zine.
Three other bathophenanthroline procedures (Roche
diagnostica, Haury, DSA 560) are included in these
comparative studies. After the addition of unlabelled
Fe3+ all free iron ions are bound to MgCO3 which is
separated from the incubation medium by centrifu-
gation. The supernatant is used for the usual determi-
nation of the iron concentration, which now indicates
the total iron binding capacity.
Materials and Methods
Materials and instruments were used as listed on Table 1 or as
reported recently (4).
Reagents for the ferrozine method were a generous gift of Dr. R.
Helger (E. Merck, D-61 Darmstadt); reagents for the Res-O-Mat
method were kindly given by Byk-Mallinckrodt Chemische Pro-
dukte GmbH (D-6051 Dietzenbach); and reagents for the Irosorb
method were a gift from Deutsche Abbott GmbH (D-6507 Ingel-
heim).
The iron concentration was determined with a Beckman DSA 560
analyzer (4). This value was added to the unbound (or free) iron
binding capacity in the radiochemical and the Merckotest proce-
dures.
The transferrin concentration was determined either directly by a
radial immunodiftusion technique using Partigen plates (4) or
indirectly measuring the amount of iron bound to the protein.
1 Mole transferrin binds 2 Fe3+ ions. Since the molecular weight
of transferrin is appro*. 89000 (5), the concentration of trans-
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ferrin in mg/100 ml is multiplied by 0.2247 to get the transferrin-
iron binding capacity in μπιοΐ/ΐ.
All cohrimetric procedures used for these comparative studies
employ bathophenanthroline as the chromogen, with the ex-
ception of the ferrozinc method (6). The DSA-method for the
determination of the total iron binding capacity was recently
described in detail (4). Values listed under Haury, Roche and
Mcrckotest \vere obtained by strictly following the recommenda-
tions of the manufacturer (Tab. 1) of the corresponding reagent
kits. The radiochemical methods differ in the step at wich free and
protein-bound iron ions are separated from each other.
Res-O-Mat Fe™: The Res-O-Mat strip extracts all free Fe3+ from
the incubation medium. The counts per minute before (pre-
counts) and after (post-counts) this step are measured. The latent
iron bindung capacity (^g/100 ml) is calculated by multiplying a
factor F (iron content of the vial in ^ g X 200) with the ratio post-
counts/pre-counts.
Irosorb-59: A resin sponge binds all free iron ions. The incubation
medium which contains the protein-bound iron fraction is aspirated
out of the vial. The sponge remaining in the vial is rinsed three
times with double distilled water. The latent iron binding capacity
is calculated as follows:
,Mg/100 ml =(- post-counts per minutepre-counts per minute •F.
(F = the amount of iron added to the incubation vial in
X 100.)
L is a correction factor specific for each reagent kit lot which is
supplied by the manufacturer.
The conversion factor from ^t/g/100 ml iron to /imol/1 is 0.1791.
All solutions are prepared with deionized and quarz distilled
water (approx. 0.5 μ8). For all methods plastic materials were
used if possible. The glassware is washed in a standard machine,
then soaked in concentrated HC1 and rinsed carefully with double
distilled H20.
For the investigation of the hemoglobin interference 3 samples were
prepared:
I. 9 ml serum + 1 ml hemoglobin solution,
Π. 9 ml serum + 1 ml 9 g/1 NaCl and
ΙΠ. 9 ml 9 g/1 NaCl .-f 1 ml hemoglobin solution. The hemo-
globin solution was prepared according to LEHMANN and HUNTS-
MAN (7). After the preparation, the hemoglobin content was
measured by a cyan-methemoglobin method (8).
Statistical Analysis
The precision from day-to-day for the determination of the iron
binding capacity in control sera was estimated as recently described
(4). The variance of reproduction (precision within-series) was
calculated as follows
l N
s2 =^-.-Z(yii —yis)2;
coefficient of variation (CV) = s/y · 100 (%). The total variance
(Var) of any method (sample i yields the values yijj j = 1, 2) was
determined by the following equation
The standardized variance (SV = s2/var. 100%) indicates the
percentage of s2 on the total variance (HAINDL, H., MARISS, P. &
HULTSCH, E., unpublished work).
All procedures were compared with the reference method (xjj
values; j = 1.2): the differences were significant in all cases as
judged by a two-way layout analysis. When systematic analytical
errors are inherent to the methods applied the equation for the
regression line can be written
Yij = a + bxi + ei + fj.
ei indicates the error about the regression introduced by inter-
sample variation of interfering substances and fj the error caused
by the analytical variability (precision within-$eries). Assuming
that both errors are independent of each other, the total variance
about regression can be split into the variance of reproduction
(var (fj) = s2) and the intersaraple variance about the regression
var (ei). To compare var (ej) between the various methods the
coefficient of variation (CV*) is preferrred.
Results and Discussion *
r
Precision
The precision from-day-to-day of the methods applied
was determined with commercial control sera (Tab. 2)
and found comparable for all procedures. The precision
within-series (reproducibility) was calculated for each
method from duplicate determinations. For comparing
the precision between the various methods the coeffi-
cient of variation (CV) and especially the standardized
variance, which is invariant against linear transfor-
mations, should be considered (Tab. 3). The reference
method (I) yielded the best precision, method III a
larger and all other procedures almost the same variance
with human sera.
Accuracy, correlation between methods
The mean value for the total iron binding capacity
varied considerably between the methods used for
these studies. This effect can be partly attributed to
different concentrations of iron ions in the iron binding
reagent (Tab. 1).
In a preceeding communication (4) we have reported
that with increasing iron concentration the binding
capacity of human sera for these ions is reached at
approx. 90^mol/l. With higher concentrations, a
plateau is observed rising more or less slightly. Above
approx. 300//mol/l Fe3+ the iron binding capacity
starts to increase further with the iron concentration.
The saturation curves of the iron binding capacity for
commercially available control sera (Fig. 1) either
resemble those for human sera (Behring control sera)
or differ significantly concerning the formation of a
plateau (Hyland, Seronorm, Monitrol). The behaviour
of some control sera may also vary with the lot as
demonstrated for Monitrol (Fig. 1B). In the absence of
a plateau, the value of the iron binding capacity strongly
depends on the iron concentration of the binding
reagent. Therefore, the mean values from all methods
differ much more with some control sera (Fig. 1:
Seronorm, Hyland) than with human sera (Tab. 3).
Transferrin cannot be determined by immunoprecipi-
tation in Seronorm which is based on horse setum.
The transferrin^iron binding capacity determined by an
immunological method was used as reference value
(2, 3) during these investigations. Some methods
yielded higher and one method lower values (Mercko-
test) than the reference procedure.
Since other proteins besides transferrin are known to
bind Fe3+ (1—3), indirect methods using saturating
iron concentrations must lead values for the total iron
binding capacity that are higher than the true trans-
ferrin concentration. The methods whose values are
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Tab, 1
Assay conditions for the determination of the iron binding capacity
Method Assay for saturation of serum samples Assay for determination of the iron concentration
with Fe»+
Fe»+ Sample FeCI, Buffer, mol/1 Reducing Color Buffer Photometer
/rniol/l ml ml (pH) reagent reagent (pH)
mmol/I mmol/1
DSA 560 92.5 0.2
(Merckotest Nr. 3307)*)
(
Roche Diagnostica») 60.0 0.5
(Eisenbindungskapazit t)
Merckotest 55.95 0.5
(Artikel Nr. 3313)1)
Ferrozine method 36.9 0.5
(Reagents: E. Merck)1)
Haury 59.7 0.6
(Serum-Eisentest)5)
Irosorb-59 54.6 1.0
(Abbott)·)
Res-O-Mat Fe5* 15.9 0.5
(Byk-Mallinckrodt)')
0.2 — ascorbate
7.0
1.0 — dithionite
43.0
0.1 Tris 0.294 methylamino-
(8.5) phenolsulfite
2.8
NaHSO,
15.0
0.2 Tris 0.294 ascorbate
(7,8) 13.0
0.2 — ascorbate
15.0
1.0 — —
3.0 Tris 0.05 —
(8.5)
bathophenan-
throline»)
0.11
bathophenan-
throline1)
0.3
bathophenan-
throline»)
0.16
ferrozine4)
263 mg/I
bathophenan-
throline»)
0.26
—
—
phosphate (5.5) DSA 560 (530 nm)
0.1 mmol/1 (Beckman Instruments)
? Eppendorf 1101 (546 nm)
Tris (7.8) Eppendorf 1101 (546 nm)
238 mmol/1
Tris (7.8) Eppendorf 1101 (546 nm)
263 mmol/1
? Eppendorf 1101 (546 nm)
— y-Scintillation
Spectrometer 5375
(Packard)
— y-Scintillation
Spectrometer 5375
(Packard)
*) E. Merck AG (D-61 Darmstadt); 2) 4.7-diphenyl-1.10-phenanthroline-disulfonic acid (bathophenanthroline); a) Deutsche Hoffmann-La Roche (D-7887
Grenzach); 4) 3-(2-pyridyl)-5.6-bis(4-phenylsulfonic acid)-1.2.4-triazine (ferrozine); ·) Dr. H. Haury (D-8 Munich 23); «) Deutsche Abbott GmbH (D-6507
Ingelheim); ') Byk-Mallinckrodt Chemische Produkte GmbH (D-6 Frankfurt).
Tab. 2
The precision from-day-to-day of various procedures for the determination of the iron binding capacity.
LIBC » latent, TIBC « total iron binding capacity
Controlserum
Seronorm
Lot No. 117
Monitrol I
Lot No. 114
Hyland
Lot. No. RO4
Transferrin
I
0
61.2
5.8
(Π)
56.2
8.2
(7)
Roche
II
92.5*)
7.5
(ID
120.5
4.6
(10)
107.0
2.4
(6)
Haury
III
72.0
4.2
(11)
86.1
2.7
(9)
65.5
6.0
(6)
DSA
IV
75.5
3.6
(20)
101.7
5.7
(20)
77.7
6.9
(20)
Merckotest
V
51.7
5.1
(12)
54.1
4.1
(10)
41.2
2.6
(7)
Ferrozine
VI
61.4
9.4
(10)
61.9
5.0
(9)
52.0
5.3
(5)
Irosorb
LIBC + Fe
VII
74.5
5.7
(9)
77.0
3.7
(10)
71.1
6.3
(6)
Res-O-Mat
TIBC LIBC-l-Fe
VIII IX
61.2
3.5
(10)
67.4
4.1
(12)
62.7
2.7
(5)
63.7
3.5
(Π)
69.4
3.2
(Π)
60.2
4.9
(6)
*) Mean value with coefficient of variation and number of contributing values (in parenthesis).
Tab. 3
Comparison of various methods for the determination of the iron binding capacity in serum samples from unselected patients of a medical poly-
clinic
Method
Mean (x)1)
ns)
r«)
var (f j) = s*
Standardized
variance (%)
CV (%)·)
(Reproduction)
var(eO
CV* (%)
(Regression)
Transferrin
I
58.7
93
—1.2
0.9
1.9
—
—
Roche
II
69.5
83
0.771
4.7
3.2
3.1
55.5
10.7
Haury
III
65.1
92
0.725
24.9
11.7
7.7
77.6
13.5
DSA
IV
67.2
75
0.790
6.2
3.8
3.7
57.0
11.2
Merckotest
LIBC-f Fe5)
V
46.0
65
0.887
0.9
0.9
2.0
21.1
10.0
Ferrozine
LIBC-fFe«)
VI
56.3
63
0.802
5.0
3.3
4.0
50.3
12.6
Res-O-Mat
TIBC«)
VII
57.7
92
0.878
4.2
4.4
3.6
18.3
7.4
LIBC-f-Fe«)
VIII
58.6
86
0.909
2.3
2.2
2.6
16.3
6.9
Irosorb
LIBC-f-Fe6)
IX
73.1
85
0.698
9.8
8.1
4.3
52.8
9.9
*) Mean value of all determinations (2n) in /imol/1 (total iron binding capacity). *) Pairs of observations. ') Coefficient of correlation.
*) Coefficient of variation. *) Latent iron binding capacity + iron concentration (^mol/l) determined according to (4).
0 Total iron binding capacity.
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below the reference procedure must be rejected. If the
same value is found for an indirect and the direct
determination of the total iron binding capacit)^ the
acceptance of this indirect method must be decided
individually. As long as the clinical significance of the
non-transferrin proteins binding iron ions is unknown,
we prefer to include this percentage. For the binding
of Fe3+ ions we, therefore, use an iron concentration
(90 μπιοΐ/ΐ) at which the plateau part of the saturation
curve begins in human sera, and which is close too that
(81 μΐηοΐ/ΐ) proposed by GIOVANNIELLO and PECCI
(9).
With regard to the fact that quite different techniques
were applied, the correlation appears acceptable for all
methods (Tab. 3 and Fig. 2). The least variance about
regression was observed with methods VII and VIII
(Tab. 3). All other procedures were comparable con-
cerning var (d) and CV.
Hemoglobin interference
Hemoglobin is reported (11) to increase the value of the
total iron binding capacity in colorimetric procedures
(Tab. 4). However, this interference is not detected
with immunological and radiochemical methods as
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Comparison of the total iron
binding capacity with the trans-
ferrin binding capacity in va-
rious human sera. The dotted
lines represent the ideal, the
drawn lines the calculated
regression. LIBC + Fe means
the concentration of latent iron
bindingcapacity plus iron deter-
mined according to 1. c. (4),
TIBC total iron binding capa-
city determined with the Res-
OMat technique from Byk-
Mallinckrodt
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Tab. 4
The influence of hemoglobin on the determination of the total iron binding capacity Oumol/1) of human pool serum by various methods. I A 76 g/l
hemoglobin stock solution was added to human pool serum to give final hemoglobin concentrations of 0.5, 1.5 and 7.5 g/l. II Physiological NaCl
solution (9 g/l) + pool serum, I I I 76 g/l hemoglobin solution -|- physiological NaCl solution. Each value is a mean of 2 determinations
Sample Hemoglobin
concentration
I 0.5
II —
III 0.5
I 1.5
II —
III 1.5
I 7.5
II —
1 1 If 7.5
DSA 560 Merckotest
52 33
54 33
<1 <1
55 29
54 32
<1 <1
64
54
12
Total iron binding capacity (μπιοΙ/Ι)
Roche Haury Transferrin
diagnostica
62
60
1
65
60
4
66
60
8
56
55
4
81
68
10
96
80
31
39
39
<1
34
35
<1
33
33
.
<l
Irosorb
I
31
33
6
28
28
14
Res-O-Mat
TIBC
43
42
10
44
39
7
42
44
16
shown in experiments where various concentrations
of hemoglobin were added to human sera (Tab. 4). In
the absence of serum (III in Tab. 4) hemoglobin was
precipitated and it apparently absorbed some labelled
Fe3+ which led to false values for the iron binding
capacity.
Conclusion ·, \
Method I (Tab. 2 and 3) determines the transferrin
concentration from which the transferrin binding
capacity can be calculated. This can be distinguished
from the total iron binding capacity. Methods II—IV
and apparently method IX determine the total iron
binding capacity of human serum (but not that of
several control sera). Method VI—VIII yield the total
iron binding capactiy minus a small part of unknown
origin. The results equal the transferrin binding capa-
city. At the moment it cannot be decided whether this
congruence occurs by chance or whether these me-
thods are specific for the transferrin binding capacity.
In comparison with the immunoprecipitation method
the Res-O-Mat procedure gave the best results. All
other methods (except method V) appeared acceptable
for diagnostic purposes. The Haury and Irosorb
method had the lowest coefficient of correlation and
the highest variance (reproduction). With the mecha-
nization of procedures for immunoprecipitation, these
methods are now to be preferred.
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